Rwanda

in page functions
[French]
Rwanda
Total population (2018) 12,438,690
Birth cohort (2018) 363,802
Surviving Infants (surviving to 1 year per year, 2018) 348,597
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 31/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 42/1000
World Bank Index, IDA (2015) 4.04
Gross Nation Income (per capita US$, 2015) 700
Co-financing group (2018) Initial self-financing
No. of districts/territories (2017) 30

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Rwanda

Type of support

Approvals

2001-2023 (US$)
(26 Sep 2018)

Commitments

2001-2023 (US$)
(26 Sep 2018)

Disbursements

2000-2018 (US$)
(26 Sep 2018)

% Disbursed

(26 Sep 2018)
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
Total $150,770,543 $151,436,751 $149,051,847
Cold Chain Equipment Optimisation Platform (CCEOP) $1,264,691 $1,930,899
Health system strengthening (HSS 1) $5,605,000 $5,605,000 $5,605,000 100%
Health system strengthening (HSS 2) $13,291,970 $13,291,970 $9,854,460 74%
HPV (NVS) $7,331,034 $7,331,034 $7,342,181 100%
Immunisation services support (ISS) $2,958,700 $2,958,700 $2,958,700 100%
Injection Safety Devices (NVS) $386,500 $386,500 $410,069 106%
Injection safety support (INS) $369,500 $369,500 $369,500 100%
IPV (NVS) $342,774 $342,774 $307,090 90%
Measles (NVS) $555,942 $555,942 $421,015 76%
Measles-Rubella (NVS) $3,549,500 $3,549,500 $3,622,489 102%
MR - Operational costs (OPC) $3,279,500 $3,279,500 $3,279,500 100%
MR 1st and 2nd dose (NVS) $4,500 $4,500 $4,915 109%
MR-Follow-up campaign (NVS) $983,490 $983,490 $983,490 100%
MR-Follow-up campaign op.costs (OPC) $923,434 $923,434 $923,434 100%
Penta (NVS) $46,873,848 $46,873,848 $47,352,836 101%
Pneumo (NVS) $35,739,192 $35,739,192 $38,149,992 107%
Product Switch Grant (PSG) $87,707 $87,707 $87,707 100%
Rotavirus (NVS) $25,819,611 $25,819,611 $25,975,819 101%
Vaccine Introduction Grant (VIG) $1,403,650 $1,403,650 $1,403,650 100%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Rwanda DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2017)

Grade of confidence


N/A
DTP3 - Official country estimates (2017) 99%
M:F sex ratio at birth (2018) 1.02
Household survey: DTP3 coverage for male (2014) 98.50%
Household survey: DTP3 coverage for female (2014) 97.80%
Household survey: Last DTP3 survey (2014) 98%
% districts achieving > 80% DTP3 coverage (2017) 100%
% districts achieving < 50% DTP3 coverage (2017) 0%
MCV WHO/UNICEF estimates (2017) 95%

Breakdown of support

Non-vaccine support Vaccine support
16% 84%
$24,481,951 $124,569,896

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Rwanda

11 June 2018

New immunisation leadership and management training

The Expanded Programme on Immunization Leadership and Management Programme (EPI LAMP) aims to strengthen national leadership and management of immunisation programmes in Gavi-supported countries. The inaugural nine-month programme is a collaboration between Yale’s Global Health Leadership Initiative, the Rwanda-based University of Global Health Equity, PATH and Gavi.

09 May 2018

IFPW STEP

IFPW and Gavi expand leadership training for a stronger supply chain

The partnership draws on private sector support to implement an innovative training and mentorship programme for supply chain managers in Gavi-supported countries.

07 May 2018

Rwanda - FB Live

New management training for immunisation leaders kicks-off in Kigali

24 managers from five Gavi-supported countries will attend the first round of the nine-month programme.

Disclaimer: the boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of Gavi, the Vaccine Alliance concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.

close icon

modal window here